165 filings
Page 4 of 9
8-K
xwxvvv6oph19
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
49x4cg98sivasl
11 Mar 21
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
8:08am
8-K
a5k4 vohr
28 Jan 21
Other Events
8:11am
8-K
8fitwzas1whuz
27 Jan 21
Other Events
4:11pm
8-K
f4zr2u
12 Nov 20
PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
4:12pm
8-K
pmjncyh
23 Oct 20
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:20am
8-K
8fi 5eyp99lzlryfb56
6 Oct 20
Other Events
8:09am
8-K
ow9593q
11 Aug 20
PhaseBio Reports Recent Business Highlights and Second-Quarter 2020 Financial Results
4:09pm
8-K
b4kxay kyelt
16 Jul 20
Other Events
4:10pm
8-K
dscmnsp
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:36pm
8-K
xcei k70l12j
27 May 20
PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
4:11pm
8-K
7aid0vjfbumumy0v
12 May 20
PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
4:08pm
S-8
w9z86cbf nsncrxlxarw
30 Mar 20
Registration of securities for employees
8:29am
8-K
fo5fpzg8dkrp
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am